igeahub.com
Top Pharma News - April 2016 - IgeaHub
AbbVie Agrees to Buy Stemcentrx April 28, 2016 Pharmaceutical company AbbVie Inc. has agreed to acquire Stemcentrx Inc., a cancer-drug developer, for $5.8